CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Stephan Zeiter |
| Publication date | October 22, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |